Risk of cancer in patients with psoriasis on biological therapies: a systematic review.

Peleva, E

Risk of cancer in patients with psoriasis on biological therapies: a systematic review. [electronic resource] - The British journal of dermatology 01 2018 - 103-113 p. digital

Publication Type: Journal Article; Meta-Analysis; Systematic Review

1365-2133

10.1111/bjd.15830 doi


Adalimumab--adverse effects
Adult
Biological Products--adverse effects
Dermatologic Agents--adverse effects
Epidemiologic Methods
Etanercept--adverse effects
Female
Humans
Infliximab--adverse effects
Male
Middle Aged
Neoplasms--chemically induced
Psoriasis--drug therapy
Risk Factors
Ustekinumab--adverse effects